IO Biotech (IOBT) News Today $1.81 -0.08 (-4.23%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.81 0.00 (0.00%) As of 08/8/2025 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IOBT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period IO Biotech (IOBT) Expected to Announce Quarterly Earnings on TuesdayAugust 6 at 10:28 AM | marketbeat.comShort Interest in IO Biotech, Inc. (NASDAQ:IOBT) Grows By 213.1%August 5, 2025 | marketbeat.comIO Biotech: Cylembio Targeting Advanced Melanoma Continues Towards Q3 PFS Data ReleaseJuly 26, 2025 | seekingalpha.comIO Biotech files to sell 4.22M shares of common stock for holdersJuly 24, 2025 | msn.comPrivate equity firms are IO Biotech, Inc.'s (NASDAQ:IOBT) biggest owners and were rewarded after market cap rose by US$16m last weekJuly 16, 2025 | finance.yahoo.comNASDAQ:IOBT Financials | IO Biotech Inc - Investing.comJuly 10, 2025 | investing.comIO Biotech (NASDAQ:IOBT) Shares Up 1.4% - Here's What HappenedJuly 9, 2025 | marketbeat.comIOBT IO Biotech, Inc. - Seeking AlphaJune 29, 2025 | seekingalpha.comIO Biotech, Inc. (NASDAQ:IOBT) Short Interest Down 35.0% in MayJune 17, 2025 | marketbeat.comWall Street Zen Upgrades IO Biotech (NASDAQ:IOBT) to "Sell"June 14, 2025 | marketbeat.comCitadel Advisors LLC Purchases Shares of 270,504 IO Biotech, Inc. (NASDAQ:IOBT)June 7, 2025 | marketbeat.comIO Biotech Regains Nasdaq Compliance with Stock PriceJune 4, 2025 | msn.comIO Biotech, Inc. (NASDAQ:IOBT) Director Acquires $20,850.00 in StockJune 3, 2025 | insidertrades.comIO Biotech, Inc. (NASDAQ:IOBT) Sees Large Growth in Short InterestJune 2, 2025 | marketbeat.comHeidi Hunter Buys 15,000 Shares of IO Biotech, Inc. (NASDAQ:IOBT) StockJune 2, 2025 | marketbeat.comIO Biotech files for the sale of up to 5.6M shares of common stock for holdersMay 23, 2025 | msn.comIO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare ConferenceMay 20, 2025 | globenewswire.comQ2 Earnings Forecast for IO Biotech Issued By HC WainwrightMay 20, 2025 | marketbeat.comIO Biotech price target raised to $14 from $12 at H.C. WainwrightMay 15, 2025 | finance.yahoo.comIO Biotech Reports First Quarter 2025 Financial Results and Business HighlightsMay 14, 2025 | globenewswire.comIO Biotech unveils promising vaccine preclinical dataApril 27, 2025 | investing.comIO Biotech Presents New Preclinical Data Supporting Dual-Antigen and TGF-β-Directed Vaccines for Enhancing Anti-Tumor Immunity at AACR 2025April 27, 2025 | nasdaq.comIO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025April 26, 2025 | globenewswire.comDauntless Investment Group LLC Acquires Shares of 747,646 IO Biotech, Inc. (NASDAQ:IOBT)April 26, 2025 | marketbeat.comIO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170April 25, 2025 | globenewswire.comIO Biotech, Inc. (NASDAQ:IOBT) Short Interest Up 156.6% in MarchApril 17, 2025 | marketbeat.comWe're A Little Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn RateApril 12, 2025 | finance.yahoo.comLandscape Capital Management L.L.C. Purchases Shares of 442,196 IO Biotech, Inc. (NASDAQ:IOBT)April 10, 2025 | marketbeat.comQ1 Earnings Estimate for IO Biotech Issued By HC WainwrightApril 6, 2025 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for IO Biotech (IOBT)April 2, 2025 | markets.businessinsider.comIO Biotech (NASDAQ:IOBT) Receives "Buy" Rating from HC WainwrightApril 2, 2025 | marketbeat.comShort Interest in IO Biotech, Inc. (NASDAQ:IOBT) Increases By 54.8%March 31, 2025 | marketbeat.comIO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual MeetingMarch 25, 2025 | globenewswire.comIO Biotech Named Among Fast Company’s World’s Most Innovative Companies of 2025March 18, 2025 | finance.yahoo.comIO Biotech Named Among Fast Company's World's Most Innovative Companies of 2025March 18, 2025 | globenewswire.comShort Interest in IO Biotech, Inc. (NASDAQ:IOBT) Increases By 32.9%March 17, 2025 | marketbeat.comIO Biotech (NASDAQ:IOBT) Upgraded at Piper SandlerMarch 15, 2025 | marketbeat.comPiper Sandler Keeps Their Buy Rating on IO Biotech (IOBT)March 12, 2025 | markets.businessinsider.comHC Wainwright Reaffirms "Buy" Rating for IO Biotech (NASDAQ:IOBT)March 6, 2025 | marketbeat.comIO Biotech, Inc. (NASDAQ:IOBT) Sees Large Decrease in Short InterestMarch 4, 2025 | marketbeat.comIO Biotech Reports 2024 Business HighlightsMarch 4, 2025 | globenewswire.comIO Biotech (IOBT) to Release Quarterly Earnings on TuesdayFebruary 25, 2025 | marketbeat.comIO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO ConferenceFebruary 23, 2025 | globenewswire.comIO Biotech to Present at the 45th Annual Cowen Health Care ConferenceFebruary 20, 2025 | globenewswire.comIO Biotech (NASDAQ:IOBT) Shares Up 4.2% - What's Next?February 19, 2025 | marketbeat.comIO Biotech announces publication of preclinical data on IO112February 4, 2025 | markets.businessinsider.comIO Biotech advances cancer vaccine candidate IO112February 4, 2025 | msn.comIO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine CandidateFebruary 4, 2025 | globenewswire.comIO Biotech, Inc. (NASDAQ:IOBT) Short Interest UpdateJanuary 28, 2025 | marketbeat.comJefferies maintains IO Biotech Buy rating, $8 target on PFS hopesJanuary 28, 2025 | msn.com Get IO Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for IOBT and its competitors with MarketBeat's FREE daily newsletter. Email Address IOBT Media Mentions By Week IOBT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IOBT News Sentiment▼0.310.38▲Average Medical News Sentiment IOBT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IOBT Articles This Week▼21▲IOBT Articles Average Week Get IO Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for IOBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Phathom Pharmaceuticals News Today Keros Therapeutics News Today Relay Therapeutics News Today Bicara Therapeutics News Today Tilray Brands News Today Organogenesis News Today Xencor News Today Maravai LifeSciences News Today Taysha Gene Therapies News Today Tourmaline Bio News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IOBT) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IO Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IO Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.